Rite Aid (NYSE:RAD) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share guidance of ($0.03)-($0.01) for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.00. The company issued revenue guidance of $21.8-$21.95 billion, compared to the consensus revenue estimate of $21.80 billion.Rite Aid also updated its FY 2019 guidance to $-0.03–0.01 EPS.
RAD traded down $0.04 on Wednesday, hitting $0.81. 15,049,414 shares of the stock traded hands, compared to its average volume of 16,678,164. Rite Aid has a 52 week low of $0.80 and a 52 week high of $2.55. The company has a quick ratio of 0.94, a current ratio of 1.62 and a debt-to-equity ratio of 2.41. The firm has a market capitalization of $875.44 million, a price-to-earnings ratio of -40.55 and a beta of 1.42.
Rite Aid (NYSE:RAD) last issued its quarterly earnings results on Wednesday, December 19th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.02. Rite Aid had a negative return on equity of 1.97% and a net margin of 3.26%. The firm had revenue of $5.45 billion for the quarter, compared to analyst estimates of $5.45 billion. Rite Aid’s quarterly revenue was up 1.8% compared to the same quarter last year.
TRADEMARK VIOLATION WARNING: This article was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/4028377/rite-aid-rad-updates-fy19-earnings-guidance.html.
Rite Aid Company Profile
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Featured Story: How to use beta for portfolio diversification
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.